New England Journal of Medicine reaffirms that Merck lied about Vioxx safety
In another editorial under the heading “Expression of Concern Reaffirmed,” three top scientists in the world Gregory D. Curfman, M.D., Stephen Morrissey, Ph.D., and Jeffrey M. Drazen, M.D. are taking on Merck that has the reputation of destroying the career of anyone who has ever questioned the safety of Vioxx – a drug that has killed as many as 60,000 Americans, according to the FDA.
While Merck has been fighting almost 10,000 personal injury lawsuits, it has not yet admitted that Vioxx caused so many deaths in America alone. The editors write, “..conclusions regarding the safety of rofecoxib were misleading.” In fact the manner in which Merck explained the fatal risks of Vioxx (Aleve was better; not that Vioxx was worse) has already become a joke among the scientists who know how Merck played with words.
The editors conclude by saying that they are not yet convinced that Vioxx was a safe drug and Merck’s published research “did not accurately reflect the potential for serious cardiovascular toxicity with rofecoxib (technical name for the drug).” This has clearly been a big setback to the company after it was celebrating its victory in the first federal retrial. The juries in the forthcoming trials are bound to hear this argument so that they can make up their minds about the injuries caused by the drug.
Recommended articles: Top cardiologist Dr Eric Topol agrees with New England Journal of Medicine editors
Merck admits that Vioxx is dangerous for short-term users too
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.
Comments
No comments yet.
Sorry, the comment form is closed at this time.